# FDA Inspection 1149848 - Nathan Segall, MD, CPI - August 13, 2021

Source: https://www.keypedia.com/records/fda_inspections/nathan-segall-md-cpi/d419d9be-264b-4e08-bc33-52733e113728
Source feed: FDA_Inspections

> FDA Inspection 1149848 for Nathan Segall, MD, CPI on August 13, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1149848
- Company Name: Nathan Segall, MD, CPI
- Inspection Date: 2021-08-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1054003 - 2018-04-26](https://www.keypedia.com/records/fda_inspections/nathan-segall-md-cpi/0cfa43b6-43c4-4eb9-b10d-14b695af79bd)

Company: https://www.keypedia.com/companies/nathan-segall-md-cpi/57b62630-1f2a-4d45-9ec0-d9419571c116

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d